Who qualifies for compounded GLP1s through Amble
[16] Peppard PE, Young T, Palta M, Dempsey J, Skatrud J
This means tirzepatide is the first agent to be develop that targets both GIP and GLP-1 hormones
Drug Discov Today 24(1):256262 Yaribeygi H, Maleki M, Sathyapalan T, Jamialahmadi T, Sahebkar A (2020a) Anti-inflammatory potentials of incretin-based therapies used in the management of diabetes
[PubMed] Younossi ZM, Wong VW, Anstee QM, Romero-Gomez M, Trauner MH, Harrison SA, Lawitz EJ, Okanoue T, Camargo M, Kersey K, Myers RP, Goodman Z, Stepanova M (2020) Fatigue and pruritus in patients with advanced fibrosis due to nonalcoholic steatohepatitis: The impact on patient-reported outcomes
Alosi MC et al